Polyrizon Stock (NASDAQ:PLRZ)
Previous Close
$11.06
52W Range
$2.88 - $18.20
50D Avg
$13.78
200D Avg
$10.65
Market Cap
$12.97M
Avg Vol (3M)
$43.08K
Beta
-1.84
Div Yield
-
PLRZ Company Profile
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.